Cargando…
Transforming growth factor-β signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation
T cell specific deletion of the Transforming growth factor-β (TGF-β) receptor mediated by CD4-cre leads to early onset lethal autoimmune disease that cannot be controlled by regulatory T cells. However, when we delete the receptor using distal Lck (dLck) promoter driven cre, adult mice in which the...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380154/ https://www.ncbi.nlm.nih.gov/pubmed/22634866 http://dx.doi.org/10.1038/ni.2319 |
Sumario: | T cell specific deletion of the Transforming growth factor-β (TGF-β) receptor mediated by CD4-cre leads to early onset lethal autoimmune disease that cannot be controlled by regulatory T cells. However, when we delete the receptor using distal Lck (dLck) promoter driven cre, adult mice in which the majority of peripheral CD4(+) and CD8(+) T cells lacked the TGF-β receptor, showed no signs of autoimmunity. Due to their heightened response to weak T cell receptor stimuli, when transferred into lymphopenic recipients, naive TGF-β unresponsive T cells exhibited dramatically enhanced proliferation, effector differentiation, and induced lymphoproliferative disease. We propose that TGF-β signaling controls self-reactivity of peripheral T cells but in the absence of TGF-β signals, an added trigger, such as lymphopenia, is required to drive overt autoimmune disease. |
---|